Seminal contributionsSperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: a prospective, observational study and validation of the SpermCOVID test
Under an Elsevier user license
open archive
Key Words
DNA fragmentation index
infertility
real-time quantitative PCR
test validation
transmission risk
Cited by (0)
Supported in part by Femicare Vereniging zonder Winstoogmerk (VZW) and AML (R20-014). AML and Femicare financed the testing and patient expenses. None of the investigators received any remuneration.
G.G.G.D. has nothing to disclose. E.B. has nothing to disclose. J.R. has nothing to disclose. F.D. has nothing to disclose. J.J. has nothing to disclose. G.S. has nothing to disclose. N.S. has nothing to disclose. Y.J. has nothing to disclose. W.O. has nothing to disclose. C.E.D. has nothing to disclose.
©2021 American Society for Reproductive Medicine, Published by Elsevier Inc.